{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:14:59Z","timestamp":1776863699138,"version":"3.51.2"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Fund, China","doi-asserted-by":"crossref","award":["81460036"],"award-info":[{"award-number":["81460036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"Background<\/jats:title>The aim of this study was to investigate patient survival and factors associated with survival in second primary non-Hodgkin lymphoma (NHL) compared with the first primary NHL.<\/jats:p><\/jats:sec>Methods<\/jats:title>The retrospective cohort study used data from the Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2014. Demographic characteristics, histological types, Ann Arbor stage, and treatment information were collected. Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for factors associated with overall survival (OS) and cancer-specific survival (CSS) in the first and second primary NHLs.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 318,168 cases followed for 5 years, 299,248 patients developed the first primary NHL and 18,920 patients developed the second primary NHL. This study identified a rising incidence of first and second primary NHL from 2000 to 2014. For the second primary NHL, the OS risk was higher when compared to the first primary NHL (HR: 1.13, 95% CI: 1.11 to 1.15,P<\/jats:italic><0.001). Risk factors that negatively affected OS in the first primary NHL included being male, over 40 years of age, certain marital statuses, specific histological types, and advanced disease stages. In contrast, being of White race and having histological types such as Follicular Lymphoma (FL), Marginal Zone Lymphoma (MZL), and mantle B-cell NHL were associated with better OS outcomes. Treatments like surgery, radiation therapy, and chemotherapy were associated with a lower risk of OS and CSS in the first primary NHL. For the second primary NHL, the detrimental risk factors were similar but also included being over the age of 60. Certain histological types showed a lower OS risk relative to diffuse Large B-cell Lymphoma (DLBCL). While surgery and chemotherapy were beneficial for OS, radiation therapy did not improve survival in second primary NHL cases. Notably, undergoing chemotherapy for the first primary cancer increased the OS risk in the second primary NHL, whereas surgery and radiation seemed to offer a protective effect against OS risk in the second primary NHL (allP<\/jats:italic><0.05).<\/jats:p><\/jats:sec>Conclusion<\/jats:title>Our findings emphasize the need for tailored strategies in managing the second primary NHL, given the distinct survival patterns and risk factor profiles compared to the first primary NHL. Future research should aim to further elucidate these differences to improve prognosis and treatment approaches for second primary NHL patients.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0300330","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T17:24:05Z","timestamp":1710177845000},"page":"e0300330","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and survival of second primary non-Hodgkin lymphoma: A Surveillance, Epidemiology, and End Results-based cohort study"],"prefix":"10.1371","volume":"19","author":[{"given":"Nasha","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangxiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7076-2834","authenticated-orcid":true,"given":"Wuping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"issue":"3","key":"pone.0300330.ref001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA: a cancer journal for clinicians"},{"issue":"1","key":"pone.0300330.ref002","article-title":"Epidemiology of Non-Hodgkin\u2019s Lymphoma","volume":"9","author":"KC Thandra","year":"2021","journal-title":"Medical sciences (Basel, Switzerland)"},{"issue":"9","key":"pone.0300330.ref003","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/ijc.34163","article-title":"Global patterns of non-Hodgkin lymphoma in 2020","volume":"151","author":"A Mafra","year":"2022","journal-title":"International journal of cancer"},{"issue":"7","key":"pone.0300330.ref004","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.3390\/curroncol29070393","article-title":"A Descriptive Study of the Types and Survival Patterns of Saudi Patients with Multiple Primary Solid Malignancies: A 30-Year Tertiary Care Center Experience","volume":"29","author":"MS Alhamadh","year":"2022","journal-title":"Current oncology (Toronto, Ont)"},{"issue":"6","key":"pone.0300330.ref005","first-page":"2863","article-title":"Trends in the risk of second primary malignances after non-Hodgkin\u2019s lymphoma","volume":"12","author":"J Li","year":"2022","journal-title":"American journal of cancer research"},{"issue":"8","key":"pone.0300330.ref006","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1182\/bloodadvances.2021006369","article-title":"Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study","volume":"6","author":"J Joelsson","year":"2022","journal-title":"Blood advances"},{"issue":"11","key":"pone.0300330.ref007","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1002\/cam4.3037","article-title":"Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades","volume":"9","author":"W Liu","year":"2020","journal-title":"Cancer medicine"},{"issue":"2","key":"pone.0300330.ref008","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaad.2019.07.075","article-title":"Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis","volume":"83","author":"A Goyal","year":"2020","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"13","key":"pone.0300330.ref009","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1200\/JCO.21.01841","article-title":"Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies","volume":"40","author":"E Pasqual","year":"2022","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"2","key":"pone.0300330.ref010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jha2.108","article-title":"The impact of prior malignancies on the development of second malignancies and survival in follicular lymphoma: A population-based study","volume":"1","author":"MAW Dinnessen","year":"2020","journal-title":"EJHaem"},{"issue":"1","key":"pone.0300330.ref011","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12957-020-01868-x","article-title":"Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study","volume":"18","author":"C Shen","year":"2020","journal-title":"World journal of surgical oncology"},{"issue":"4","key":"pone.0300330.ref012","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ijc.32391","article-title":"Second primary cancers in non-Hodgkin lymphoma: Family history and survival","volume":"146","author":"S Chattopadhyay","year":"2020","journal-title":"International journal of cancer"},{"issue":"6","key":"pone.0300330.ref013","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/bju.14841","article-title":"Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis","volume":"124","author":"E Mazzone","year":"2019","journal-title":"BJU international"},{"issue":"34","key":"pone.0300330.ref014","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1200\/JCO.19.00129","article-title":"Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort","volume":"37","author":"LM Turcotte","year":"2019","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"19","key":"pone.0300330.ref015","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1002\/cncr.30164","article-title":"Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008","volume":"122","author":"N Donin","year":"2016","journal-title":"Cancer"},{"issue":"4","key":"pone.0300330.ref016","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hon.2302","article-title":"Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up","volume":"35","author":"T Tadmor","year":"2017","journal-title":"Hematological oncology"},{"issue":"8","key":"pone.0300330.ref017","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/annonc\/mdq697","article-title":"Risk for second malignancies in non-Hodgkin\u2019s lymphoma survivors: a meta-analysis","volume":"22","author":"M Pirani","year":"2011","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"key":"pone.0300330.ref018","first-page":"9570171","article-title":"Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer","volume":"2016","author":"MJ Liou","year":"2016","journal-title":"International journal of endocrinology"},{"issue":"1","key":"pone.0300330.ref019","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1186\/s12885-019-5744-8","article-title":"Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis","volume":"19","author":"C He","year":"2019","journal-title":"BMC cancer"},{"key":"pone.0300330.ref020","first-page":"9636790","article-title":"A Novel Prognostic Model for Patients with Primary Gastric Diffuse Large B-Cell Lymphoma","volume":"2022","author":"G Lu","year":"2022","journal-title":"Journal of oncology"},{"issue":"6","key":"pone.0300330.ref021","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ejca.2010.11.014","article-title":"Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database","volume":"47","author":"BL Frederiksen","year":"2011","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"issue":"5","key":"pone.0300330.ref022","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/bjc.2012.3","article-title":"Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark\u2014a nationwide study","volume":"106","author":"BL Frederiksen","year":"2012","journal-title":"British journal of cancer"},{"issue":"32","key":"pone.0300330.ref023","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1200\/JCO.19.00812","article-title":"Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children\u2019s Oncology Group Study","volume":"37","author":"JM Kahn","year":"2019","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"6","key":"pone.0300330.ref024","first-page":"e25867","article-title":"Racial Disparities in Survival Among Non-Hodgkin Lymphoma Patients: An Analysis of the SEER Database (2007\u20132015)","volume":"14","author":"FO Abodunrin","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"pone.0300330.ref025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canep.2014.12.001","article-title":"Racial differences in three major NHL subtypes: descriptive epidemiology","volume":"39","author":"Y Li","year":"2015","journal-title":"Cancer epidemiology"},{"issue":"10","key":"pone.0300330.ref026","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.3109\/10428194.2015.1007505","article-title":"Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma","volume":"56","author":"C Rossi","year":"2015","journal-title":"Leukemia & lymphoma"},{"issue":"10","key":"pone.0300330.ref027","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/ijc.27889","article-title":"Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France","volume":"132","author":"A Monnereau","year":"2013","journal-title":"International journal of cancer"},{"key":"pone.0300330.ref028","doi-asserted-by":"crossref","first-page":"e2100265","DOI":"10.1200\/GO.21.00265","article-title":"Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study","volume":"8","author":"M Pavlovsky","year":"2022","journal-title":"JCO global oncology"},{"issue":"10091","key":"pone.0300330.ref029","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"JO Armitage","year":"2017","journal-title":"Lancet (London, England)"},{"key":"pone.0300330.ref030","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2147\/CMAR.S369086","article-title":"Clinical Features Analysis and Survival Nomogram of Primary Small Intestinal Diffuse Large B-Cell Lymphoma","volume":"14","author":"X Liu","year":"2022","journal-title":"Cancer management and research"},{"issue":"3","key":"pone.0300330.ref031","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijrobp.2009.02.045","article-title":"Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with and without radiation: a surveillance, epidemiology, and end-results analysis","volume":"76","author":"TJ Pugh","year":"2010","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"20","key":"pone.0300330.ref032","article-title":"Role of Radiation Therapy in Mortality among Adolescents and Young Adults with Lymphoma: Differences According to Cause of Death","volume":"14","author":"X Yin","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"pone.0300330.ref033","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9110147","article-title":"Clinical and Functional Assays of Radiosensitivity and Radiation-Induced Second Cancer","volume":"9","author":"M Habash","year":"2017","journal-title":"Cancers"},{"key":"pone.0300330.ref034","doi-asserted-by":"crossref","first-page":"906125","DOI":"10.3389\/fonc.2022.906125","article-title":"Endoscopic Screening for Second Primary Tumors of the Esophagus Among Head and Neck Cancer Patients","volume":"12","author":"CS Chung","year":"2022","journal-title":"Frontiers in oncology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0300330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T03:29:27Z","timestamp":1731554967000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0300330"}},"subtitle":[],"editor":[{"given":"Tinashe","family":"Mudzviti","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0300330","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]}}}